Table of Contents Author Guidelines Submit a Manuscript
TheScientificWorldJOURNAL
Volume 9, Pages 909-919
http://dx.doi.org/10.1100/tsw.2009.99
Review Article

Immunotherapeutic Strategies for Alzheimer's Disease Treatment

Department of Molecular Microbiology and Biotechnology, George S. Wise Faculty of Life Sciences, Tel-Aviv University, Tel Aviv, Israel

Received 17 June 2009; Revised 6 August 2009; Accepted 6 August 2009

Academic Editor: Rudy Tanzi

Copyright © 2009 Beka Solomon.

Citations to this Article [10 citations]

The following is the list of published articles that have cited the current article.

  • De Chang, Jian-Hua Zhang, Xue-Mei Zhao, and Ping Liang, “Vector construction and expression of anti-Aß human-mouse chimeric antibody against Alzheimer's disease,” Chinese Journal of Pathology, vol. 39, no. 8, pp. 542–547, 2010. View at Publisher · View at Google Scholar
  • Dong-Hyuk Park, David J. Eve, Yong-Gu Chung, and Paul R. Sanberg, “Regenerative Medicine for Neurological Disorders,” Thescientificworldjournal, vol. 10, pp. 470–489, 2010. View at Publisher · View at Google Scholar
  • Marta Marin-Argany, Geovanny Rivera-Hernandez, Joaquim Marti, and Sandra Villegas, “An anti-A beta (amyloid beta) single-chain variable fragment prevents amyloid fibril formation and cytotoxicity by withdrawing A beta oligomers from the amyloid pathway,” Biochemical Journal, vol. 437, pp. 25–34, 2011. View at Publisher · View at Google Scholar
  • David J. Eve, Cesar V. Borlongan, and Paul R. Sanberg, “A Showcase of Bench-to-Bedside Regenerative Medicine at the 2010 ASNTR,” The Scientific World JOURNAL, vol. 11, pp. 1842–1864, 2011. View at Publisher · View at Google Scholar
  • Wolfgang Froestl, Andrea Pfeifer, and Andreas Muhs, “Cognitive Enhancers (Nootropics). Part 3: Drugs Interacting with Targets other than Receptors or Enzymes. Disease-modifying Drugs,” Journal Of Alzheimers Disease, vol. 34, no. 1, pp. 1–114, 2013. View at Publisher · View at Google Scholar
  • Yuan Zhang, Yuanhong Sun, Yangyang Huai, and Ying-Jiu Zhang, “Functional Characteristics and Molecular Mechanism of a New scFv Antibody Against Aβ42 Oligomers and Immature Protofibrils,” Molecular Neurobiology, 2014. View at Publisher · View at Google Scholar
  • Laia Montoliu-Gaya, and Sandra Villegas, “Protein structures in Alzheimer's disease: The basis for rationale therapeutic design,” Archives of Biochemistry and Biophysics, 2015. View at Publisher · View at Google Scholar
  • Laia Montoliu-Gaya, and Sandra Villegas, “Aβ-Immunotherapeutic strategies: a wide range of approaches for Alzheimer's disease treatment,” Expert Reviews in Molecular Medicine, vol. 18, 2016. View at Publisher · View at Google Scholar
  • Natalia V. Bobkova, Vadim V. Novikov, Natalia I. Medvinskaya, Irina Y. Aleksandrova, Inna V. Nesterova, and Eugenii E. Fesenko, “Effect of weak combined static and extremely low-frequency alternating magnetic fields on spatial memory and brain amyloid-β in two animal models of Alzheimer’s disease,” Electromagnetic Biology and Medicine, pp. 1–11, 2018. View at Publisher · View at Google Scholar
  • Laia Montoliu-Gaya, and Sandra Villegas, “Immunotherapy for neurodegenerative diseases: the Alzheimer's disease paradigm,” Current Opinion in Chemical Engineering, vol. 19, pp. 59–67, 2018. View at Publisher · View at Google Scholar